Request for Covid-19 Impact Assessment of this Report
Scope of the Report:
This report studies the Stem Cell Therapy for Osteoarthritis market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Stem Cell Therapy for Osteoarthritis market by product type and applications/end industries.
The expected growth is because of increasing awareness of osteoarthritis and increasing diagnosis rates, rising older population, and increasing cases of obesity. Osteoarthritis is directly related to obesity, with approximately 35% of osteoarthritis patients suffering from obesity.
The global Stem Cell Therapy for Osteoarthritis market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Stem Cell Therapy for Osteoarthritis.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Mesoblast
Regeneus
U.S. Stem Cell
Anterogen
Asterias Biotherapeutics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Monotherapy
Combination Therapy
Market Segment by Applications, can be divided into
Osteoarthritis (unspecified)
Knee Osteoarthritis
Shoulder Osteoarthritis
Hip Osteoarthritis
1 Stem Cell Therapy for Osteoarthritis Market Overview
1.1 Product Overview and Scope of Stem Cell Therapy for Osteoarthritis
1.2 Classification of Stem Cell Therapy for Osteoarthritis by Types
1.2.1 Global Stem Cell Therapy for Osteoarthritis Revenue Comparison by Types (2017-2023)
1.2.2 Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Types in 2017
1.2.3 Monotherapy
1.2.4 Combination Therapy
1.3 Global Stem Cell Therapy for Osteoarthritis Market by Application
1.3.1 Global Stem Cell Therapy for Osteoarthritis Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Osteoarthritis (unspecified)
1.3.3 Knee Osteoarthritis
1.3.4 Shoulder Osteoarthritis
1.3.5 Hip Osteoarthritis
1.4 Global Stem Cell Therapy for Osteoarthritis Market by Regions
1.4.1 Global Stem Cell Therapy for Osteoarthritis Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Stem Cell Therapy for Osteoarthritis Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Stem Cell Therapy for Osteoarthritis Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Stem Cell Therapy for Osteoarthritis Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Stem Cell Therapy for Osteoarthritis Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Stem Cell Therapy for Osteoarthritis Status and Prospect (2013-2023)
1.5 Global Market Size of Stem Cell Therapy for Osteoarthritis (2013-2023)
2 Manufacturers Profiles
2.1 Mesoblast
2.1.1 Business Overview
2.1.2 Stem Cell Therapy for Osteoarthritis Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Mesoblast Stem Cell Therapy for Osteoarthritis Revenue, Gross Margin and Market Share (2016-2017)
2.2 Regeneus
2.2.1 Business Overview
2.2.2 Stem Cell Therapy for Osteoarthritis Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Regeneus Stem Cell Therapy for Osteoarthritis Revenue, Gross Margin and Market Share (2016-2017)
2.3 U.S. Stem Cell
2.3.1 Business Overview
2.3.2 Stem Cell Therapy for Osteoarthritis Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 U.S. Stem Cell Stem Cell Therapy for Osteoarthritis Revenue, Gross Margin and Market Share (2016-2017)
2.4 Anterogen
2.4.1 Business Overview
2.4.2 Stem Cell Therapy for Osteoarthritis Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Anterogen Stem Cell Therapy for Osteoarthritis Revenue, Gross Margin and Market Share (2016-2017)
2.5 Asterias Biotherapeutics
2.5.1 Business Overview
2.5.2 Stem Cell Therapy for Osteoarthritis Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Asterias Biotherapeutics Stem Cell Therapy for Osteoarthritis Revenue, Gross Margin and Market Share (2016-2017)
3 Global Stem Cell Therapy for Osteoarthritis Market Competition, by Players
3.1 Global Stem Cell Therapy for Osteoarthritis Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Stem Cell Therapy for Osteoarthritis Players Market Share
3.2.2 Top 10 Stem Cell Therapy for Osteoarthritis Players Market Share
3.3 Market Competition Trend
4 Global Stem Cell Therapy for Osteoarthritis Market Size by Regions
4.1 Global Stem Cell Therapy for Osteoarthritis Revenue and Market Share by Regions
4.2 North America Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
4.3 Europe Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
4.5 South America Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
5 North America Stem Cell Therapy for Osteoarthritis Revenue by Countries
5.1 North America Stem Cell Therapy for Osteoarthritis Revenue by Countries (2013-2018)
5.2 USA Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
5.3 Canada Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
5.4 Mexico Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
6 Europe Stem Cell Therapy for Osteoarthritis Revenue by Countries
6.1 Europe Stem Cell Therapy for Osteoarthritis Revenue by Countries (2013-2018)
6.2 Germany Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
6.3 UK Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
6.4 France Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
6.5 Russia Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
6.6 Italy Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Stem Cell Therapy for Osteoarthritis Revenue by Countries
7.1 Asia-Pacific Stem Cell Therapy for Osteoarthritis Revenue by Countries (2013-2018)
7.2 China Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
7.3 Japan Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
7.4 Korea Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
7.5 India Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
8 South America Stem Cell Therapy for Osteoarthritis Revenue by Countries
8.1 South America Stem Cell Therapy for Osteoarthritis Revenue by Countries (2013-2018)
8.2 Brazil Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
8.3 Argentina Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
8.4 Colombia Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Stem Cell Therapy for Osteoarthritis by Countries
9.1 Middle East and Africa Stem Cell Therapy for Osteoarthritis Revenue by Countries (2013-2018)
9.2 Saudi Arabia Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
9.3 UAE Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
9.4 Egypt Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
9.5 Nigeria Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
9.6 South Africa Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
10 Global Stem Cell Therapy for Osteoarthritis Market Segment by Type
10.1 Global Stem Cell Therapy for Osteoarthritis Revenue and Market Share by Type (2013-2018)
10.2 Global Stem Cell Therapy for Osteoarthritis Market Forecast by Type (2018-2023)
10.3 Monotherapy Revenue Growth Rate (2013-2023)
10.4 Combination Therapy Revenue Growth Rate (2013-2023)
11 Global Stem Cell Therapy for Osteoarthritis Market Segment by Application
11.1 Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Application (2013-2018)
11.2 Stem Cell Therapy for Osteoarthritis Market Forecast by Application (2018-2023)
11.3 Osteoarthritis (unspecified) Revenue Growth (2013-2018)
11.4 Knee Osteoarthritis Revenue Growth (2013-2018)
11.5 Shoulder Osteoarthritis Revenue Growth (2013-2018)
11.6 Hip Osteoarthritis Revenue Growth (2013-2018)
12 Global Stem Cell Therapy for Osteoarthritis Market Size Forecast (2018-2023)
12.1 Global Stem Cell Therapy for Osteoarthritis Market Size Forecast (2018-2023)
12.2 Global Stem Cell Therapy for Osteoarthritis Market Forecast by Regions (2018-2023)
12.3 North America Stem Cell Therapy for Osteoarthritis Revenue Market Forecast (2018-2023)
12.4 Europe Stem Cell Therapy for Osteoarthritis Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Stem Cell Therapy for Osteoarthritis Revenue Market Forecast (2018-2023)
12.6 South America Stem Cell Therapy for Osteoarthritis Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Stem Cell Therapy for Osteoarthritis Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Stem Cell Therapy for Osteoarthritis Picture
Table Product Specifications of Stem Cell Therapy for Osteoarthritis
Table Global Stem Cell Therapy for Osteoarthritis and Revenue (Million USD) Market Split by Product Type
Figure Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Types in 2017
Figure Monotherapy Picture
Figure Combination Therapy Picture
Table Global Stem Cell Therapy for Osteoarthritis Revenue (Million USD) by Application (2013-2023)
Figure Stem Cell Therapy for Osteoarthritis Revenue Market Share by Applications in 2017
Figure Osteoarthritis (unspecified) Picture
Figure Knee Osteoarthritis Picture
Figure Shoulder Osteoarthritis Picture
Figure Hip Osteoarthritis Picture
Table Global Market Stem Cell Therapy for Osteoarthritis Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Stem Cell Therapy for Osteoarthritis Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Stem Cell Therapy for Osteoarthritis Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Stem Cell Therapy for Osteoarthritis Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Stem Cell Therapy for Osteoarthritis Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Stem Cell Therapy for Osteoarthritis Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Stem Cell Therapy for Osteoarthritis Revenue (Million USD) and Growth Rate (2013-2023)
Table Mesoblast Basic Information, Manufacturing Base and Competitors
Table Mesoblast Stem Cell Therapy for Osteoarthritis Type and Applications
Table Mesoblast Stem Cell Therapy for Osteoarthritis Revenue, Gross Margin and Market Share (2016-2017)
Table Regeneus Basic Information, Manufacturing Base and Competitors
Table Regeneus Stem Cell Therapy for Osteoarthritis Type and Applications
Table Regeneus Stem Cell Therapy for Osteoarthritis Revenue, Gross Margin and Market Share (2016-2017)
Table U.S. Stem Cell Basic Information, Manufacturing Base and Competitors
Table U.S. Stem Cell Stem Cell Therapy for Osteoarthritis Type and Applications
Table U.S. Stem Cell Stem Cell Therapy for Osteoarthritis Revenue, Gross Margin and Market Share (2016-2017)
Table Anterogen Basic Information, Manufacturing Base and Competitors
Table Anterogen Stem Cell Therapy for Osteoarthritis Type and Applications
Table Anterogen Stem Cell Therapy for Osteoarthritis Revenue, Gross Margin and Market Share (2016-2017)
Table Asterias Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table Asterias Biotherapeutics Stem Cell Therapy for Osteoarthritis Type and Applications
Table Asterias Biotherapeutics Stem Cell Therapy for Osteoarthritis Revenue, Gross Margin and Market Share (2016-2017)
Table Global Stem Cell Therapy for Osteoarthritis Revenue (Million USD) by Players (2013-2018)
Table Global Stem Cell Therapy for Osteoarthritis Revenue Share by Players (2013-2018)
Figure Global Stem Cell Therapy for Osteoarthritis Revenue Share by Players in 2016
Figure Global Stem Cell Therapy for Osteoarthritis Revenue Share by Players in 2017
Figure Global Top 5 Players Stem Cell Therapy for Osteoarthritis Revenue Market Share in 2017
Figure Global Top 10 Players Stem Cell Therapy for Osteoarthritis Revenue Market Share in 2017
Figure Global Stem Cell Therapy for Osteoarthritis Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Stem Cell Therapy for Osteoarthritis Revenue (Million USD) by Regions (2013-2018)
Table Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Regions (2013-2018)
Figure Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Regions (2013-2018)
Figure Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Regions in 2017
Figure North America Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
Figure Europe Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
Figure South America Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
Table North America Stem Cell Therapy for Osteoarthritis Revenue by Countries (2013-2018)
Table North America Stem Cell Therapy for Osteoarthritis Revenue Market Share by Countries (2013-2018)
Figure North America Stem Cell Therapy for Osteoarthritis Revenue Market Share by Countries (2013-2018)
Figure North America Stem Cell Therapy for Osteoarthritis Revenue Market Share by Countries in 2017
Figure USA Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
Figure Canada Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
Figure Mexico Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
Table Europe Stem Cell Therapy for Osteoarthritis Revenue (Million USD) by Countries (2013-2018)
Figure Europe Stem Cell Therapy for Osteoarthritis Revenue Market Share by Countries (2013-2018)
Figure Europe Stem Cell Therapy for Osteoarthritis Revenue Market Share by Countries in 2017
Figure Germany Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
Figure UK Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
Figure France Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
Figure Russia Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
Figure Italy Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Stem Cell Therapy for Osteoarthritis Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Stem Cell Therapy for Osteoarthritis Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Stem Cell Therapy for Osteoarthritis Revenue Market Share by Countries in 2017
Figure China Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
Figure Japan Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
Figure Korea Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
Figure India Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
Table South America Stem Cell Therapy for Osteoarthritis Revenue by Countries (2013-2018)
Table South America Stem Cell Therapy for Osteoarthritis Revenue Market Share by Countries (2013-2018)
Figure South America Stem Cell Therapy for Osteoarthritis Revenue Market Share by Countries (2013-2018)
Figure South America Stem Cell Therapy for Osteoarthritis Revenue Market Share by Countries in 2017
Figure Brazil Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
Figure Argentina Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
Figure Colombia Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Stem Cell Therapy for Osteoarthritis Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Stem Cell Therapy for Osteoarthritis Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Stem Cell Therapy for Osteoarthritis Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Stem Cell Therapy for Osteoarthritis Revenue Market Share by Countries in 2017
Figure Saudi Arabia Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
Figure UAE Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
Figure Egypt Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
Figure Nigeria Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
Figure South Africa Stem Cell Therapy for Osteoarthritis Revenue and Growth Rate (2013-2018)
Table Global Stem Cell Therapy for Osteoarthritis Revenue (Million USD) by Type (2013-2018)
Table Global Stem Cell Therapy for Osteoarthritis Revenue Share by Type (2013-2018)
Figure Global Stem Cell Therapy for Osteoarthritis Revenue Share by Type (2013-2018)
Figure Global Stem Cell Therapy for Osteoarthritis Revenue Share by Type in 2017
Table Global Stem Cell Therapy for Osteoarthritis Revenue Forecast by Type (2018-2023)
Figure Global Stem Cell Therapy for Osteoarthritis Market Share Forecast by Type (2018-2023)
Figure Global Monotherapy Revenue Growth Rate (2013-2018)
Figure Global Combination Therapy Revenue Growth Rate (2013-2018)
Table Global Stem Cell Therapy for Osteoarthritis Revenue by Application (2013-2018)
Table Global Stem Cell Therapy for Osteoarthritis Revenue Share by Application (2013-2018)
Figure Global Stem Cell Therapy for Osteoarthritis Revenue Share by Application (2013-2018)
Figure Global Stem Cell Therapy for Osteoarthritis Revenue Share by Application in 2017
Table Global Stem Cell Therapy for Osteoarthritis Revenue Forecast by Application (2018-2023)
Figure Global Stem Cell Therapy for Osteoarthritis Market Share Forecast by Application (2018-2023)
Figure Global Osteoarthritis (unspecified) Revenue Growth Rate (2013-2018)
Figure Global Knee Osteoarthritis Revenue Growth Rate (2013-2018)
Figure Global Shoulder Osteoarthritis Revenue Growth Rate (2013-2018)
Figure Global Hip Osteoarthritis Revenue Growth Rate (2013-2018)
Figure Global Stem Cell Therapy for Osteoarthritis Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Stem Cell Therapy for Osteoarthritis Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Stem Cell Therapy for Osteoarthritis Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Stem Cell Therapy for Osteoarthritis Revenue Market Forecast (2018-2023)
Figure Europe Stem Cell Therapy for Osteoarthritis Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Stem Cell Therapy for Osteoarthritis Revenue Market Forecast (2018-2023)
Figure South America Stem Cell Therapy for Osteoarthritis Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Stem Cell Therapy for Osteoarthritis Revenue Market Forecast (2018-2023)
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...